Detecting the “big C” – saving lives

pink ribbon

Advancements in medical science are saving lives and we should all be grateful. If you have been “touched” by cancer, particularly bowel cancer, you will already know that early detection is vital because the growths can often be removed, painlessly, before they have the chance to develop into cancer. IF YOU DON’T TEST FOR IT YOU DO NOT KNOW IT IS THERE.

Detecting the “big C” – saving business

In no way am I attempting to trivialise this “breakthrough” but I cannot help but to draw a comparison to illustrate the point in relation to business. A fast-growing cancer is affecting business across the globe…COMPLEXITY. It is not something that is currently tested for…because, until recently, there was no test. Complexity exists within every dynamic system (business) and can grow rapidly attacking the structure and robustness of the business until its impact manifests itself in, for example, the financial data. Every system has a current and critical complexity threshold BUT you do not know where you stand or what your tolerance is until to test for it.

As someone whose partner has recently undergone surgery and chemotherapy for breast cancer (and another family member with lymphoma) the threat of this awful disease has been, very much, on my mind. We consider ourselves very lucky that the disease was spotted so early and have spent a lot of time alerting others to the dangers of assuming that, because all appears well on the surface, that it is necessarily so.

Through my recent work to establish Ontonix UK and to introduce Quantitative complexity management as a business discipline I am attempting to communicate a similar message to the UK business community. If you can help or would like more information please get in touch.

The good news is that it doesn’t involve the insertion of a camera – we offer an on-line option – and the basic costs are not prohibitive even for the smallest business.

New study marks major advance in bowel cancer screening

An image of a Flexi-Scope

A new one-off bowel test could reduce deaths by 40 per cent

What if having your bowel investigated with a tiny camera – just once – could greatly reduce the risk of dying from bowel cancer and of developing the disease in the first place? Striking new results from an important study show that this is very real possibility.

We don’t often use the word breakthrough – but this is one of those rare occasions. Thousands of people could be saved from developing bowel cancer because of this test and thousands more could be diagnosed early when treatment is most effective.

As Harpal Kumar, our Chief Executive Officer, said, “This is one of the most important developments in cancer research for years.”

For the past 16 years, Professor Wendy Atkin from Imperial College London has been coordinating a trial of a test called flexible sigmoidoscopy or, more commonly, ‘Flexi-Scope’. It involves a tube called an endoscope, which has a tiny camera and light at the end of it.

Cancer Research UK is proud to have supported much of Professor Atkin’s work, including part-funding this trial.

Related articles by Zemanta

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s